Pre-Recorded

Plenary Presentation

Transplant

Bronchoscopic lung volume reduction (BLVR) for the treatment of symptomatic maximally treated chronic obstructive lung disease provides an emerging treatment for patients who meet criteria. Studies have reported that patients treated with BLVR experienced improvement in FEV1, FVC, 6-minute walk distance, and symptomatic measures. These impressive improvements do not come without risk, with serious post-procedural adverse event rates ranging from 21% to 47.7%. This interactive session will present the data for the procedure, patient selection criteria, and managment of complications in an interactive, case-based format aimed at improving patient selection and incorporation of BLVR into the practicing clinician's treatment paradigm.

At the end of this session, learners will be able to describe patient outcome data associated with bronchoscopic lung volume reduction.

At the end of this session, learners will be able to identify patients that should be referred for consideration of bronchoscopic lung volume reduction.